我国《基本药物目录》与世界卫生组织《基本药物目录》比较研究

A Comparative Study on the Essential Medicines Lists Between China and WHO

目的:比较我国《基本药物目录》与世界卫生组织(WHO)《基本药物目录》的异同,促进我国《基本药物目录》的调整。方法:从我国《基本药物目录》与WHO《基本药物目录》制定的背景、分类体系、药物收载数量等方面进行比较,分析二者之间的联系和差异。结果与结论:我国《基本药物目录》以WHO《基本药物目录》为指导,具有同源性,但在分类体系、数量、内容上存在一定差异。我国应参考WHO《基本药物目录》,调整并颁布符合我国国情的《基本药物目录》。

OBJECTIVE： To compare between China and WHO the difference of the Essential Medicine List （EML） . METHODS： The relation and differences between China and WHO were analyzed by comparing the background, the classification system and quantity of Essential Medicines. RESULTS ＆ CONCLUSION： Chinese EML is based on WHO EML, and these two EMLs are congenetic. But there are some differences between China and WHO in classification system, quantity and content of Essential medicines. We should modify and issue EML according to the situation of our country by referring to WHO EML.